The Journal of Organic Chemistry
ARTICLE
(E)-2,4-Di(pyridin-2-yl)-6-styrylpyrimidine (2a). Aliquat 336
(20 mg, 0.049 mmol), benzaldehyde (60 mg, 0.570 mmol), 4-methyl-
2,6-di(pyridin-2-yl)pyrimidine 1 (118 mg, 0.475 mmol), and aqueous 5
M NaOH (10 mL) were placed in a 50 mL round-bottomed flask. The
reaction mixture was heated under reflux with stirring for 6 h. The
mixture was allowed to cool and was diluted with water (50 mL) and
extracted with ethyl acetate (3 ꢁ 20 mL). The combined organic extracts
were dried (MgSO4), filtered, and evaporated under reduced pressure.
The residue was purified by column chromatography (alumina, eluent:
hexane/ethyl acetate, 3:7) to give 117 mg (73%) of 2a as a beige solid.
Mp 170ꢀ171 °C. 1H NMR (500 MHz, CDCl3) δ 7.35ꢀ7.46 (m, 6H),
7.77 (d, 2H, J = 7.5 Hz), 7.92 (dt, 2H, J = 2.0 and 8.0 Hz), 8.04 (d, 1H, J =
16.5 Hz), 8.53 (s, 1H), 8.70 (dt, 1H, J = 1.0 and 8.0 Hz), 8.74 (dt, 1H, J =
1.0 and 8.0 Hz), 8.78 (dq, 1H, J = 1.0 and 4.5 Hz), 8.92 (dq, 1H, J = 1.0
and 5.0 Hz). 13C NMR and DEPT (125 MHz, CDCl3) δ 112.8 (CH),
122.2 (CH), 124.0 (CH), 124.7 (CH), 125.4 (CH), 127.0 (CH), 127.7
(CH), 128.9 (CH), 129.3 (CH), 135.9 (C), 136.8 (CH), 137.1 (CH),
137.5 (CH), 149.4 (CH), 150.1 (CH), 154.2 (C), 155.4 (C), 163.4 (C),
163.5 (C), 165.1 (C). IR (ATR) ν 1639, 1576, 1556, 1523, 1367, 972,
808, 767 cmꢀ1. MALDI-TOF m/z 336.7 [Mþ]. Anal. Calcd for
C22H16N4 (336.14): C, 78.55; H, 4.79; N, 16.66. Found: C, 78.30; H,
4.92; N, 16.36.
(E)-4-(4-Methylstyryl)-2,6-di(pyridin-2-yl)pyrimidine (2b).
This compound was prepared from Aliquat 336 (46 mg, 0.113 mmol),
4-methylbenzaldehyde (176 mg, 1.47 mmol), and 4-methyl-2,6-di-
(pyridin-2-yl)pyrimidine 1 (280 mg, 1.23 mmol) using the same
procedure described for 2a. The reaction mixture was heated under
reflux with stirring for 2 h. The residue was purified by crystallization
from a mixture of EtAcO/hexanes (10 mL, 1/1) to give 275 mg (64%) of
2b as a beige solid. Mp 142ꢀ144 °C. 1H NMR (500 MHz, CDCl3) δ
2.39 (s, 3H), 7.23 (d, 2H, J = 8.0 Hz), 7.38 (d, 1H, J = 16.0 Hz),
7.42ꢀ7.46 (m, 2H), 7.57 (d, 2H, J = 8.0 Hz), 7.91 (td, 2H, J = 1.5 and 7.5
Hz), 8.01 (d, 1H, J = 16.0 Hz), 8.51 (s, 1H), 8.70 (dt, 1H, J = 1.0 and 7.5
Hz), 8.73 (dt, 1H, J = 1.0 and 7.5 Hz), 8.77 (br d, 1H, J = 4.5 Hz), 8.91
(br d, 1H, J = 4.5 Hz). 13C NMR and DEPT (125 MHz, CDCl3) δ 21.4
(CH3), 112.7 (CH), 122.1 (CH), 123.9 (CH), 124.7 (CH), 125.4
(CH), 126.0 (CH), 127.7 (CH), 129.6 (CH), 133.1 (C), 136.9 (CH),
137.1 (CH), 137.5 (CH), 139.6 (C), 149.4 (CH), 150.1 (CH), 154.2
(C), 155.4 (C), 163.4 (C), 163.5 (C), 165.0 (C). IR (ATR) ν 1633,
1577, 1564, 1557, 1520, 1368, 968, 826, 764 cmꢀ1. MALDI-TOF m/z
350.5 [Mþ]. Anal. Calcd for C23H18N4: C, 78.83; H, 5.18; N, 15.99.
Found: C, 78.50; H, 4.92; N, 15.76.
procedure described for 2a. The reaction mixture was heated under reflux
with stirring for 2 h. The residue was purified by column chromatography
(alumina, eluent: hexane/ethyl acetate, 1:1) to give 295 mg (60%) of 2d as a
yellow solid. Mp 181ꢀ182 °C. 1H NMR (500 MHz, CDCl3) δ 7.04ꢀ7.11
(m, 4H), 7.12ꢀ7.18 (m, 4H), 7.27ꢀ7.34 (m, 5H), 7.40ꢀ7.46 (m, 2H),
7.52 (d, 2H, J = 8.5 Hz), 7.91 (td, 2H, J = 2.0 and 8.0 Hz), 7.99 (d, 1H, J =
16.0 Hz), 8.49 (s, 1H), 8.69 (br d, 1H, J = 8.0 Hz), 8.73 (br d, 1H, J = 8.0
Hz), 8.76 (br d, 1H, J = 4.5 Hz), 8.91 (br d, 1H, J = 4.5 Hz). 13C NMR and
DEPT (125 MHz, CDCl3) δ 112.4 (CH), 122.1 (CH), 122.2 (CH), 123.7
(CH), 123.9 (CH), 124.6 (CH), 124.7 (CH), 125.2 (CH), 125.3 (CH),
128.7 (CH), 129.2 (C), 129.4 (CH), 136.8 (CH), 137.0 (CH), 137.1
(CH), 147.1 (C), 149.0 (C), 149.4 (CH), 150.1 (CH), 154.3 (C), 155.5
(C), 163.2 (C), 163.5 (C), 165.2 (C). IR (ATR) ν 1627, 1575, 1562, 1519,
1487, 1469, 1369, 1269, 748 cmꢀ1. MALDI-TOF m/z 504.5 [M þ Hþ].
Anal. Calcd for C34H25N5 (503.21): C, 81.09; H, 5.00; N, 13.91. Found: C,
80.99; H, 5.26; N, 14.07.
(E)-4-[2-(6-Methoxynaphthalen-2-yl)vinyl]-2,6-di(pyridin-
2-yl)pyrimidine (2e). This compound was prepared from Aliquat 336
(26 mg, 0.064 mmol), 6-methoxy-2-naphthaldehyde (122 mg, 0.650
mmol), and 4-methyl-2,6-di(pyridin-2-yl)pyrimidine 1 (162 mg, 0.652
mmol) using the same procedure described for 2a. The reaction mixture
was heated under reflux with stirring for 6 h. The residue was washed
with ethanol to give 143 mg (52%) of 2e as a yellow solid. Mp
185ꢀ187 °C. 1H NMR (500 MHz, CDCl3) δ 3.95 (s, 3H),
7.15ꢀ7.20 (m, 2H), 7.42ꢀ7.46 (m, 3H), 7.61ꢀ7.83 (m, 3H),
7.85ꢀ8.10 (m, 3H), 8.20 (d, 1H, J = 16.5 Hz), 8.56 (s, 1H), 8.73 (d,
1H, J = 8.0 Hz), 8.77 (d, 1H, J = 8.0 Hz), 8.79 (br d, 1H, J = 4.5 Hz), 8.95
(br d, 1H, J = 4.0 Hz). 13C NMR and DEPT (125 MHz, CDCl3) δ 55.4
(CH3), 106.0 (CH), 112.9 (CH), 119.3 (CH), 122.2 (CH), 124.0
(CH), 124.3 (CH), 124.8 (CH), 125.5 (CH), 126.1 (CH), 127.5 (CH),
128.9 (C), 129.0 (CH), 130.0 (CH), 131.3 (C), 135.2 (C), 137.1 (CH),
137.2 (CH), 137.8 (CH), 149.4 (CH), 149.9 (CH), 154.2 (C), 155.2
(C), 158.5 (C), 163.3 (C), 163.5 (C), 165.0 (C). IR (ATR) ν 1622,
1575, 1556, 1519, 1467, 1371, 1259, 1174, 848, 780, 740, 675, 663 cmꢀ1
.
MALDI-TOF m/z 415.8 [Mþ]. Anal. Calcd for C27H20N4O (416.47):
C, 77.87; H, 4.84; N, 13.45. Found: C, 77.56; H, 4.72; N, 13.34.
(E)-2,4-Di(pyridin-2-yl)-6-(4-trifluoromethylstyryl)pyrimidine
(2f). This compound was prepared from Aliquat 336 (16 mg, 0.039 mmol),
4-(trifluoromethyl)benzaldehyde (102 mg, 0.586 mmol), 4-methyl-2,6-di-
(pyridin-2-yl)pyrimidine 1(97 mg, 0.391 mmol), and an aqueous solution of
sodium hydroxide (1 M, 15 mL) using the same procedure described for 2a.
The reaction mixture was heated under reflux with stirring for 20 h. The
residue was purified by column chromatography (alumina, eluent: hexane/
ethyl acetate, 1:1) to give 65 mg (41%) of 2f as a pale yellow solid. Mp
96ꢀ98 °C. 1H NMR (500 MHz, CDCl3) δ 7.45ꢀ7.47 (m, 2H), 7.47 (d,
1H, J = 16.5 Hz), 7.67 (d, 2H, J = 8.0 Hz), 7.76 (d, 2H, J = 8.0 Hz),
7.92ꢀ7.94 (m, 2H), 8.07 (d, 1H, J= 16.5 Hz), 8.54 (s, 1H), 8.71 (dd, 1H, J=
1.0and8.0Hz), 8.75(dd, 1H,J=1.0and8.0Hz),8.77(brd, 1H,J=4.5Hz),
8.93 (br d, 1H, J = 4.0 Hz). 13C NMR and DEPT (125 MHz, CDCl3) δ
113.3 (CH), 122.2 (CH), 124.0 (q, J = 270.2 Hz, CF3), 124.0 (CH), 124.9
(CH), 125.6 (CH), 125.8 (q, J = 3.7 Hz, CH), 127.7 (CH), 129.2 (CH),
130.7 (q, J = 32.6 Hz, C), 135.7 (CH), 137.0 (CH), 137.2 (CH), 139.2 (C),
149.5 (CH), 150.1 (CH), 153.9 (C), 155.0 (C), 163.5 (C), 163.9 (C), 164.1
(C). 19F NMR (282 MHz, CDCl3) δ ꢀ63.1. IR (ATR) ν 1555, 1369, 1379,
1163, 1109, 1065, 763 cmꢀ1. MALDI-TOF m/z 403.8 [Mþ]. Anal. Calcd
for C23H15F3N4 (404.12): C, 68.31; H, 3.74; N, 13.85. Found: C, 68.01; H,
3.83; N, 13.50.
(E)-4-(4-Dimethylaminostyryl)-2,6-di(pyridin-2-yl)pyrimidine
(2c). This compound was prepared from Aliquat 336 (52 mg, 0.126 mmol),
4-(dimethylamino)benzaldehyde (227 mg, 1.52 mmol), and 4-methyl-2,6-
di(pyridin-2-yl)pyrimidine 1 (315 mg, 1.27 mmol) using the same proce-
dure described for 2a. The reaction mixture was heated under reflux with
stirring for 2 h. The residue was washed with a hot ethanol to give 281 mg
(58%) of2c as a red solid. Mp 182ꢀ184 °C. 1H NMR (500 MHz, CDCl3) δ
3.04 (s, 6H), 6.74 (d, 2H, J = 9.0 Hz), 7.22 (d, 1H, J = 16.0 Hz), 7.41ꢀ7.45
(m, 2H), 7.57 (d, 2H, J = 8.0 Hz), 7.91 (td, 2H, J = 2.0 and 8.0 Hz), 7.98 (d,
1H, J = 16.0 Hz), 8.45 (s, 1H), 8.70 (br d, 1H, J = 8.5 Hz), 8.71 (br d, 1H, J =
8.5 Hz), 8.77 (br d, J = 4.0 Hz, 1H), 8.91 (br d, J = 4.0 Hz, 1H). 13C NMR
and DEPT (125 MHz, CDCl3) δ 40.2 (CH3), 112.0 (CH), 112.1 (CH),
122.1 (CH), 122.3 (CH), 123.9 (CH), 124.0 (C), 124.5 (CH), 125.2
(CH), 129.2 (CH), 136.6 (CH), 137.1 (CH), 138.0 (CH), 149.4 (CH),
150.1 (CH), 151.2 (C), 154.5 (C), 155.6 (C), 162.9 (C), 163.4 (C), 165.7
(C). IR (ATR) ν 1602, 1556, 1508, 1359, 1182, 974, 810, 764, 740 cmꢀ1
.
(E,E,E)-4-{3,5-Bis[4-(hexyloxy)styryl]styryl}-2,6-di(pyridin-2-yl)-
pyrimidine (2g). This compound was prepared from Aliquat 336 (12 mg,
0.029 mmol), 3,5-bis[4-(hexyloxy)styryl]benzaldehyde (165 mg, 0.323
mmol), and 4-methyl-2,6-di(pyridin-2-yl)pyrimidine 1 (73 mg, 0.294
mmol) using the same procedure described above for 2a. The residue
was dissolved in hot ethyl acetate and precipitated with cold ethanol to give
120 mg (55%) of 2g as a yellow solid. Mp 80ꢀ82 °C. 1H NMR (500 MHz,
MALDI-TOF m/z 380.4 [M þ Hþ]. Anal. Calcd for C24H21N5 (379.18):
C, 75.97; H, 5.58; N, 18.46. Found: C, 75.64; H, 5.46; N, 18.17.
(E)-4-(4-Diphenylaminostyryl)-2,6-di(pyridin-2-yl)pyrimidine
(2d). This compound was prepared from Aliquat 336 (40 mg, 0.098 mmol),
4-(diphenylamino)benzaldehyde (346 mg, 1.27 mmol), and 4-methyl-2,6-
di(pyridin-2-yl)pyrimidine 1 (242 mg, 0.975 mmol) using the same
3843
dx.doi.org/10.1021/jo200204u |J. Org. Chem. 2011, 76, 3837–3845